| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia.
|
Haematologica
|
2010
|
1.53
|
|
2
|
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.
|
Blood
|
2010
|
1.33
|
|
3
|
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.
|
Biol Blood Marrow Transplant
|
2011
|
1.24
|
|
4
|
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.
|
Blood
|
2013
|
1.21
|
|
5
|
Clinical characteristics and outcome of children with biphenotypic acute leukemia.
|
Haematologica
|
2009
|
1.07
|
|
6
|
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
|
Biol Blood Marrow Transplant
|
2013
|
1.07
|
|
7
|
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?
|
Blood
|
2012
|
1.07
|
|
8
|
Localised Ewing sarcoma/PNET of bone--prognostic factors and international data comparison.
|
Med Pediatr Oncol
|
2002
|
1.05
|
|
9
|
Ocular findings after allogeneic hematopoietic stem cell transplantation.
|
Ophthalmology
|
2009
|
1.04
|
|
10
|
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study.
|
Blood
|
2007
|
0.93
|
|
11
|
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.
|
Biol Blood Marrow Transplant
|
2012
|
0.84
|
|
12
|
Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
|
Br J Haematol
|
2015
|
0.84
|
|
13
|
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
|
Biol Blood Marrow Transplant
|
2010
|
0.81
|
|
14
|
Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.
|
Biol Blood Marrow Transplant
|
2011
|
0.80
|
|
15
|
Efficacy of vincristine and carboplatin as chemo-reduction for advanced bilateral retinoblastoma, the Saudi experience.
|
Saudi J Ophthalmol
|
2013
|
0.79
|
|
16
|
HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.
|
Biol Blood Marrow Transplant
|
2012
|
0.79
|
|
17
|
Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report.
|
Leuk Lymphoma
|
2014
|
0.78
|
|
18
|
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience.
|
Biol Blood Marrow Transplant
|
2011
|
0.77
|
|
19
|
Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO).
|
Transfus Apher Sci
|
2010
|
0.76
|
|
20
|
In cyclosporine induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire?
|
Pediatr Blood Cancer
|
2008
|
0.75
|
|
21
|
Successful outcome in two patients with CD40 deficiency treated with allogeneic HCST.
|
Clin Immunol
|
2012
|
0.75
|
|
22
|
Outcome of allogeneic stem cell transplantation with a conditioning regimen of busulfan, cyclophosphamide and low-dose etoposide for children with myelodysplastic syndrome.
|
Hematol Oncol Stem Cell Ther
|
2011
|
0.75
|
|
23
|
Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children.
|
Leuk Lymphoma
|
2012
|
0.75
|
|
24
|
Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes.
|
Hematol Oncol Stem Cell Ther
|
2011
|
0.75
|
|
25
|
Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
|
J Pediatr Hematol Oncol
|
2016
|
0.75
|